Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
The study in brief: Cancer research//Basic research//Peer review publication//Researcher-initiated study//Computer simulation//Animal study//In vitro/In vivo//In ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...
Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...
Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.